SLC6A4 binds TCAs and SSRIs

Stable Identifier
R-HSA-9714415
Type
Reaction [binding]
Species
Homo sapiens
Compartment
Synonyms
SERT binds SLC6A4 inhibitors
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Tricyclic antidepressants (TCAs) are a class of medications that are used primarily as antidepressants. They are named after their 3-ringed chemical structure. Imipramine is the prototypical TCA that was also the first to be marketed in 1957 for the treatment of various depressive states. Other TCAs include amitriptyline, clomipramine, dosulepin, doxepin, and trimipramine. The use of imipramine and other TCAs have decreased in recent decades due to the introduction of the selective serotonin reuptake inhibitors (SSRIs), which have fewer side effects. SSRIs are typically used as antidepressants in the treatment of major depressive disorder, anxiety disorders, and illnesses related to serotonin deficiencies. Marketed SSRIs include citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine and sertraline.

Both TCAs and SSRIs function by increasing the extracellular levesl of the neurotransmitter serotonin. They achieve this by limiting the reabsorption of serotonin into the presynaptic cell by blocking the sodium-dependent serotinin transporter (SERT), encoded by the SLC6A4 gene (Richelson 1991, Richelson 2001, Barker & Blakely 1996, Richelson 2003, Zhou et al. 2007, Wang et al. 2013).
Literature References
PubMed ID Title Journal Year
24121440 Structural basis for action by diverse antidepressants on biogenic amine transporters

Ressler, R, Wang, H, Wang, KH, Penmatsa, A, Goehring, A, Gouaux, E

Nature 2013
1646793 Biological basis of depression and therapeutic relevance

Richelson, E

J Clin Psychiatry 1991
11357798 Pharmacology of antidepressants

Richelson, E

Mayo Clin Proc 2001
14552650 Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance

Richelson, E

J Clin Psychiatry 2003
17690258 LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake

Reith, ME, Karpowich, NK, Law, CJ, Zhen, J, Wang, DN, Zhou, Z, Goetz, RM

Science 2007
8863842 Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter

Blakely, RD, Barker, EL

Mol Pharmacol 1996
Participants
Participates
Orthologous Events
Authored
Reviewed
Created
Cite Us!